Clinical Research

Gebro Pharma GmbH

Address
Bahnhofbichl 13

Sponsor Overview

assignment
2
sponsored trials
science
0
molecules
location_city
1
research centre
public
1
country
person_search
1
investigator

Specializations

Bioequivalence and Pharmaceutical Development

Gebro Pharma GmbH’s clinical research activity includes bioequivalence work in healthy male volunteers, with an emphasis on comparing a candidate product against an established reference medicine.

  • Bioequivalence studies
  • Healthy volunteer research
  • Reference product comparison

This area reflects a focus on therapeutic product development and the clinical assessment of pharmaceutical equivalence.

Rheumatology

The sponsor’s therapeutic interests include active rheumatoid arthritis in adults and polyarthritic forms of severe, active juvenile idiopathic arthritis, particularly where response to nonsteroidal anti-inflammatory drugs has been inadequate.

  • Rheumatoid arthritis
  • Juvenile idiopathic arthritis
  • Anti-inflammatory treatment resistance

These studies place inflammatory joint disease and immune-mediated musculoskeletal disorders within its clinical scope.

Dermatology and Psoriatic Disease

Gebro Pharma GmbH also funds research in severe recalcitrant disabling psoriasis and severe psoriatic arthritis in adult patients.

  • Psoriasis
  • Psoriatic arthritis
  • Severe inflammatory skin disease

This area links cutaneous inflammation with joint involvement, reflecting interest in conditions that affect both skin and musculoskeletal function.

Gastroenterology

The sponsor’s portfolio includes mild-to-moderate Crohn’s disease in adult patients, including those treated alone or with corticosteroids and those refractory or intolerant to thiopurines.

  • Crohn’s disease
  • Inflammatory bowel disease
  • Thiopurine intolerance

This indicates clinical interest in intestinal inflammation and treatment options for immune-mediated gastrointestinal disease.

Sponsored Trials

Trial Name Country Status
Bioequivalence Study of GP-IMP-001 in Comparison to Reference Product in Healthy VolunteersCzechia CzechiaNot Recruiting
Bioequivalence Study of GP-IMP-001 in Healthy Male Volunteers for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriasis, Psoriatic Arthritis, and Crohn's DiseaseCzechia CzechiaNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
100%
Return partnership rate
1 of 1 sites collaborated multiple times

This sponsor has worked with 1 site across their trial portfolio.

Therapeutic Focus

  • 1.
    Digestive System Diseases1 trial
    280 other sponsors
  • 2.
    Not possible to specify1 trial
    220 other sponsors
  • 3.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

1 centre
location_city
assignment24
Cepha s.r.o.
Address
Komenskeho 19, Severni Predmesti, 323 00 Pilsen
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Gebro Pharma GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.